Healthtech Startups
16,916 companies tagged Healthtech, with their investors and founders.
4D Healthware offers Virtual CCM, a technology platform for chronic care management that lets healthcare providers deliver care beyond the clinic in settings such as homes, pharmacies, grocery stores, workplaces, and online. It is aimed at healthcare providers seeking to extend patient care outside traditional clinical settings.
2 investors
4TEEN4 develops monoclonal antibody therapeutics targeting shock and critical illness in patients. The company is advancing invobenitug (procizumab), a first-in-class treatment designed to address circulating dipeptidyl peptidase 3, a molecular driver of cardiovascular dysfunction and organ failure in shock states.
2 investors
5AM Ventures is an investment firm with professionals holding expertise in science, medicine, operations, legal, and finance who identify and develop life science portfolio companies.
2 investors
A platform that connects people seeking emotional support with trained volunteer listeners via anonymous one-on-one chat, allowing users to discuss personal concerns without judgment or advice-giving.
2 investors
A clinical-stage biopharmaceutical company developing investigational therapies for patients with liver and cardiometabolic diseases, with a lead candidate (pegozafermin) being evaluated for metabolic dysfunction-associated steatohepatitis and severe hypertriglyceridemia.
2 investors
EightMedical provides on-demand ambulance and urgent medical care services, including emergency response, ambulance standby for events, ambulance transport, and urgent care. It serves individuals, event planners, hospitals, estates, schools, production companies, and HMOs in Nigeria.
2 investors
A-wave develops medical devices and related software/hardware products for healthcare applications. The company was founded by healthcare professionals with Stanford Biodesign training and conducts research in medical device innovation.
2 investors
A10 Lab Inc. develops γΏγγγ£γ¬ (Minna Challenge), a behavioral change platform that leverages community support and technology to help users achieve health and wellness goals, particularly targeting lifestyle disease prevention and frailty prevention through mobile and business solutions.
2 investors
A2 Bio develops precision CAR T-cell therapies using its Tmod cell engineering platform, supporting both autologous and allogeneic applications. The company targets cancer and other serious diseases, advancing its cell therapies through clinical trials.
2 investors
.png){kind=icon}
Abby Care provides specialized training, ongoing support, and community resources for caregivers across the U.S., focusing on easing the challenges families face when navigating care.
2 investors
Abi Global Health provides a virtual care platform combining AI and licensed healthcare professionals to deliver on-demand medical consultations across 40+ countries in 25+ languages. The platform serves insurers, employers, health systems, and governments seeking to expand healthcare access and reduce costs.
2 investors
2 investors
AbilityPharma develops innovative oncology therapies that induce autophagy to treat various cancers and address unmet medical needs. The company has advanced therapies including ibrilatazar (ABTL0812) through clinical trials for lung cancer, pancreatic cancer, and other tumor types.
2 investors
ABK Biomedical is a clinical-stage medical device company that develops x-ray visible glass microspheres for Y-90 radioembolization and embolic treatment of cancers such as liver cancer. Spun out of Dalhousie University, it serves interventional oncology and radiology applications.
2 investors
Able Health provides software for physician organizations to administer value-based care programs, including quality measure calculation and health plan coordination to reduce administrative overhead.
2 investors
Able Innovations builds the ALTA Platform, a device that lets a single caregiver transfer patients at the push of a button to reduce physical strain and protect patient skin and tissue. The product targets healthcare providers and their patient-handling workflows.
2 investors
AbsoluteCare provides whole-person, integrated primary and behavioral health care for vulnerable, chronically ill members through comprehensive care centers, community outreach, and in-home visits. Its care model addresses social drivers of health such as housing, transportation, and food security alongside medical needs.
2 investors
Abstractive Health provides AI-powered medical record summarization and pre-visit review tools for clinicians. The platform consolidates fragmented patient records and clinical data to help healthcare providers prepare for appointments with summarized patient insights.
2 investors
Acarix provides diagnostic systems and supports investigator-initiated clinical trials and research projects to advance medical knowledge in cardiovascular disease assessment.
2 investors
Access Vascular develops thrombus-evading intravascular catheters made from a proprietary biomaterial, offering an FDA-cleared PICC and the HydroMID peripherally inserted midline catheter to reduce vascular access complications. The company designs and manufactures its medical devices for clinical use in the United States.
2 investors
Accountable provides a platform that automates HIPAA compliance tasks including policies, training, risk assessments, vendor management, and incident tracking for small and mid-size healthcare organizations such as dental offices, therapy practices, and health tech startups.
2 investors
Accure Health is a company focused on developing treatments to improve the lives of patients and their relatives affected by central nervous system (CNS) diseases. It operates in the biotech sector.
2 investors
Achieve Life Sciences is a late-stage specialty pharmaceutical company developing cytisinicline, a treatment for nicotine dependence and smoking cessation. It is pursuing FDA approval for the drug as a new option for people trying to quit smoking or vaping in the US.
2 investors
Acousia Therapeutics develops small-molecule drug candidates with a dual mode of action for treating acute and chronic sensorineural hearing loss (SNHL), targeting outer hair cells in the inner ear to preserve and enhance natural hearing. The biotech company focuses on drug therapies as a first-line or complementary option to hearing aids and cochlear implants.
2 investors